The Application of Locoregional Therapy Combined With Systemic Therapy in the Perioperative Period of Huge Hepatocellular Carcinoma: A Retrospective Cohort Study
Conditions
- Huge Hepatocellular Carcinoma (HCC) (>10cm)
Interventions
- PROCEDURE: hepatectomy without immune checkpoint inhibitors-based adjuvant therapy
- PROCEDURE: hepatectomy with immune checkpoint inhibitors-based adjuvant therapy
- PROCEDURE: neoadjuvant conversion therapy followed by surgery
- DRUG: Non-surgery
Sponsor
Tongji Hospital